Skip to Main content Skip to Navigation
Theses

La kinase Aurora A comme nouvelle cible des agents chimiothérapeutiques Application aux traitements des cancers colorectaux

Abstract : The mitosis entry is associated with increase of Aurora A kinase expression. In this study, we characterise the effects of sn38, the active metabolite of irinotecan, the main drugs used in the treatment of colorectal cancer. Without treatment, the transcription factor c-myc actives the Aurora A promoter. However, the treatment of cells with sn38 induces inhibition of c-myc and prevents his association with Aurora A promoter. This treatment is also associated with induction of senescence. On the other hand, we study Ras oncogene effects on Aurora A. We observe a decrease of Aurora A expression through modulation of c-myc transcriptional cofactors activity. Our results show that Aurora A is a target of chemotherapeutics treatment and oncogenic pathways. Blocking Aurora A expression is certainly a protection against tumor development.
Complete list of metadatas

https://tel.archives-ouvertes.fr/tel-00449418
Contributor : Anne-Marie Plé <>
Submitted on : Thursday, January 21, 2010 - 3:45:16 PM
Last modification on : Friday, June 19, 2020 - 3:27:22 AM
Long-term archiving on: : Thursday, June 17, 2010 - 11:09:57 PM

Identifiers

  • HAL Id : tel-00449418, version 1

Collections

Citation

Julia Cherier. La kinase Aurora A comme nouvelle cible des agents chimiothérapeutiques Application aux traitements des cancers colorectaux. Biochimie [q-bio.BM]. Université d'Angers, 2008. Français. ⟨tel-00449418⟩

Share

Metrics

Record views

241

Files downloads

1238